These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8899849)

  • 1. A novel extravascular input function for the assessment of drug absorption in bioavailability studies.
    Weiss M
    Pharm Res; 1996 Oct; 13(10):1547-53. PubMed ID: 8899849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DeMonS--a new deconvolution method for estimating drug absorbed at different time intervals and/or drug disposition model parameters using a monotonic cubic spline.
    Yu Z; Hwang SS; Gupta SK
    Biopharm Drug Dispos; 1997 Aug; 18(6):475-87. PubMed ID: 9267681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revising Pharmacokinetics of Oral Drug Absorption: II Bioavailability-Bioequivalence Considerations.
    Chryssafidis P; Tsekouras AA; Macheras P
    Pharm Res; 2021 Aug; 38(8):1345-1356. PubMed ID: 34341958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A note on population analysis of dissolution-absorption models using the inverse Gaussian function.
    Wang J; Weiss M; D'Argenio DZ
    J Clin Pharmacol; 2008 Jun; 48(6):719-25. PubMed ID: 18359921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo evaluation of the semi-simultaneous method for bioavailability estimation using controlled intravenous infusion as an 'extravascular' route of administration.
    Bredberg U; Karlsson MO
    Biopharm Drug Dispos; 1991 Nov; 12(8):583-97. PubMed ID: 1801965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measures of exposure versus measures of rate and extent of absorption.
    Chen ML; Lesko L; Williams RL
    Clin Pharmacokinet; 2001; 40(8):565-72. PubMed ID: 11523723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the One-Compartment Model with First Order Absorption a Useful Approximation?
    Weiss M
    Pharm Res; 2023 Sep; 40(9):2147-2153. PubMed ID: 37594592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability estimation by semisimultaneous drug administration: a Monte Carlo simulation study.
    Karlsson MO; Bredberg U
    J Pharmacokinet Biopharm; 1990 Apr; 18(2):103-20. PubMed ID: 2348378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of oral extended-release dosage forms. I. Release kinetics, concentration, and absorbed fraction.
    Liu FY; Sambol NC; Giannini RP; Liu CY
    Pharm Res; 1995 May; 12(5):720-8. PubMed ID: 7479559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Models for describing absorption rate and estimating extent of bioavailability: application to cefetamet pivoxil.
    Holford NH; Ambros RJ; Stoeckel K
    J Pharmacokinet Biopharm; 1992 Oct; 20(5):421-42. PubMed ID: 1287195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of metabolite formation pharmacokinetics after intravenous and oral administration of the parent drug using inverse Laplace transformation.
    Weiss M
    Drug Metab Dispos; 1998 Jun; 26(6):562-5. PubMed ID: 9616192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of plasma enfuvirtide after subcutaneous administration to patients with human immunodeficiency virus: Inverse Gaussian density absorption and 2-compartment disposition.
    Zhang X; Nieforth K; Lang JM; Rouzier-Panis R; Reynes J; Dorr A; Kolis S; Stiles MR; Kinchelow T; Patel IH
    Clin Pharmacol Ther; 2002 Jul; 72(1):10-9. PubMed ID: 12152000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam.
    Wagner JG; Ganes DA; Midha KK; Gonzalez-Younes I; Sackellares JC; Olson LD; Affrime MB; Patrick JE
    J Pharmacokinet Biopharm; 1991 Aug; 19(4):413-55. PubMed ID: 1920088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependence of Bioavailability on Mean Absorption Time: What Does It Tell Us?
    Weiss M; Siegmund W
    AAPS J; 2023 Apr; 25(3):36. PubMed ID: 37016156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deconvolution method for assessing the absorption of a drug with reversible metabolic pathways.
    Hwang S; Knowles M
    J Pharm Sci; 1994 May; 83(5):629-31. PubMed ID: 8071809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of methods to calculate cyclosporine A bioavailability from consecutive oral and intravenous doses.
    Karlsson MO; Lindberg-Freijs A
    J Pharmacokinet Biopharm; 1990 Aug; 18(4):293-311. PubMed ID: 2231321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convolution-based approaches for in vivo-in vitro correlation modeling.
    Gillespie WR
    Adv Exp Med Biol; 1997; 423():53-65. PubMed ID: 9269483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability assessment of arginine-vasopressin (AVP) using pharmacokinetic-pharmacodynamic (PK-PD) modeling in the rat.
    Miyazaki M; Sawada S; Nishide T; Iwanaga K; Morimoto K; Kakemi M
    Biol Pharm Bull; 2000 Jan; 23(1):87-96. PubMed ID: 10706418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Input Estimation for Extended-Release Formulations Exemplified with Exenatide.
    Trägårdh M; Chappell MJ; Palm JE; Evans ND; Janzén DLI; Gennemark P
    Front Bioeng Biotechnol; 2017; 5():24. PubMed ID: 28470000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.